ESC 365 - Increased bleeding risk in cancer patients with atrial fibrillation. Can we identify risk predictors?

ESC Premium Access

Increased bleeding risk in cancer patients with atrial fibrillation. Can we identify risk predictors?

Session: Poster session 5 - Comorbidities and mortalities

Topic: Atrial fibrillation (AF)

Speaker: Doctor A. Pardo Sanz (Madrid, ES)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Ana Pardo Sanz

Ramon and Cajal University Hospital, Madrid (Spain)

0 follower

10 more presentations in this session

Cancer and risk of atrial fibrillation: a systematic review and meta-analysis.

Speaker: Doctor T. Liu (Tianjin, CN)

Mortality and atrial fibrillation in the FIACA study: evidence of a differential effect according to the diagnosis of hospital admission.

Speaker: Doctor D. Fernandez-Berges (Villanueva de la Serena, ES)

Multimorbidity and comorbidity in atrial fibrillation and effects on survival: findings from UK biobank cohort

Speaker: Professor D. Connelly (Glasgow, GB)

Patients with cancer and atrial fibrillation treated with NOACs: data from a prospective cohort

Speaker: Doctor M. Vedovati (Perugia, IT)

Comorbid malignancy as an independent predictor of in-hospital mortality in patients with atrial fibrillation.

Speaker: Doctor K. Voudris (Chicago, US)

Access the full session

Poster session 5 - Comorbidities and mortalities

Speakers: Doctor A. Pardo Sanz, Doctor T. Liu, Doctor D. Fernandez-Berges, Professor D. Connelly, Doctor M. Vedovati...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources